|
Retreatment with an interferon-free combination of simeprevir-sofosbuvir in patients who had previously failed on HCV NS5A inhibitor-based regimens
|
|
|
Reported by Jules Levin
European Resistance Workshop June 3-5 2015 Barcelona
Christophe Hezode1,2 , Stephane Chevaliez2,3, Giovanna Scoazec1, Alexandre Soulier2,3, Magali Bouvier-Alias2,3, Isaac Ruiz2,3, Ariane Mallat1,2, Cyrille Feray1,2, Jean-Michel Pawlotsky2,3
![HCV1.gif](../images/062215/062215-1/HCV1.gif)
![HCV2.gif](../images/062215/062215-1/HCV2.gif)
![HCV3.gif](../images/062215/062215-1/HCV3.gif)
![HCV4.gif](../images/062215/062215-1/HCV4.gif)
![HCV5.gif](../images/062215/062215-1/HCV5.gif)
![HCV6.gif](../images/062215/062215-1/HCV6.gif)
![HCV7.gif](../images/062215/062215-1/HCV7.gif)
![HCV8.gif](../images/062215/062215-1/HCV8.gif)
|
|
|
|
|
|
|